Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Sarcoma, Ewing × Melphalan × Clear all

Phase

Status

Completed 7 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 14 Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3 Melanoma 3 Waldenstrom Macroglobulinemia 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Skin Neoplasms 1 Sezary Syndrome 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroectodermal Tumors, Primitive 1 Mycosis Fungoides 1 Medulloblastoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

selinexor 1 liposomal doxorubicin 1 ixazomib 1 fludarabine phosphate 1 Temozolomide 1 PM 01183 1 Melphalan 1 Irinotecan 1 Erlotinib Hydrochloride 1 Busulfan 1 Biopsy, Fine-Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01969942 2017-05-09

ASCT

University of Louisville

Phase 1 Withdrawn

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡